Feedback / Questions
212 Pb-ADVC001 - AdvanCell Isotopes
https://www.businesswire.com/news/home/20251202480467/en/AdvanCell-Initiates-Phase-2-Expansion-Trial-of-ADVC001-a-Novel-Targeted-Alpha-Therapy-for-Prostate-Cancer
Dec 2, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next